… Experience and evidence from cross-discipline use of corticosteroids shows that careful …
their use. This article attempts to outline the current level of evidence for corticosteroid use in a …

… , impairment on QoL, complications of disease and therapy. Autoimmune Blistering Diseases
occurring in children can usually be managed with topical steroids with a good prognosis. …

… Eighty-nine percent of patients treated with rituximab and short-term prednisone were in
complete remission off therapy at 24 months, compared with 34% of patients treated with …

… controlled by systemic corticosteroids in combination with … Since our understanding of
autoimmune bullous diseases has … which have changed the prognosis of these diseases [11-14]. …

… to severe disease, and topical therapy for mild disease or … corticosteroid use in autoimmune
blistering diseases and also examines the adverse effects associated with corticosteroid use. …

… that the application of topical steroids over a wide area is well… for the use of IA to treat
autoimmune blistering skin diseases … on the use of IA to treat autoimmune blistering diseases (22). …

… autoimmune blistering diseases, because treatment often requires long-term immunosuppressive
therapy, … The mainstay of therapy for bullous pemphigoid is oral corticosteroids, and …

… sodium, and methotrexate) can be used in patients whose disease is not effectively controlled
with corticosteroids alone or when the use of corticosteroids is contraindicated. It may take …

… -threatening diseases. In this review, the focus is on autoimmune bullous diseases with the
… The use of systemic corticosteroids well above 1 mg/kg body weight as pulse or continuous …

… corticosteroids15, 21 and sometimes, a second-line therapy … The use of oral corticosteroids
was less frequent in our study … pemphigus after failure of local corticosteroid (90% of patients…